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Abstract 
Background: Point‑of‑care testing (POCT) systems enable a wide range of tests to be rapidly performed at the 
bedside and have attracted increasing interest in the intensive care unit (ICU). However, previous studies comparing 
the concordance of POCT with central laboratory testing have reported divergent findings. Most reported studies on 
POCT reliability have focused on analyzer performance rather than the preanalytical phase. The aim of this study was 
to assess the reliability of results provided by point‑of‑care analyzers according to the organization of the care units 
and the preanalytical process.
Methods: In three adult critical care units, 491 paired blood samples were analyzed for hemoglobin, potassium, and 
sodium concentrations by blood gas analyzers (identical reference) and the central laboratory. The clinical significance 
of agreement was assessed using Bland–Altman plots. A quality improvement program was then implemented to 
improve the preanalytical POCT process for one ICU where there was poor agreement. A second comparison was 
performed on 278 paired blood samples in this unit.
Results: Biases were clinically nonsignificant for potassium and sodium concentrations for all tested critical care 
units, relative to the reference method. However, biases [limits of agreements] for hemoglobin analyses were clearly 
affected by the preanalytical process: −3 [−6; 1] g/L in the operating room, −5 [−28; 17] g/L in a 10‑bed ICU, and 
−19 [−64; 27] g/L in a 37‑bed ICU. The quality approach was implemented in the 37‑bed ICU and led to correc‑
tive actions that: (1) reduced the time for the POCT preanalytical phase; (2) implemented a checklist to validate the 
preanalytical conditions; (3) used technical innovations. The improvement of the preanalytical process resulted in a 
substantial decrease of the bias for hemoglobin concentration measurements: −3 [−10; 5] g/L in the 37‑bed ICU.
Conclusion: We clearly demonstrate that an identical analyzer can provide results of varying quality depending on 
the local constraints of the ICUs. We demonstrate that quality management focused on the preanalytical process and 
performed by the partners involved in the POCT can overcome these issues.
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Background
Point-of-care testing (POCT) can be defined as a rapid 
biological test near the site of care of a patient or at the 
bedside [1]. One of the major advantages of POCT is 
the reduction of the laboratory test turnaround time to 
rapidly treat the patient as appropriate [2, 3]. POCT sys-
tems have been developed over the past few years and 
have enabled a wide range of tests to be rapidly and sim-
ply performed without using sophisticated central labo-
ratory equipment. Intensive care units (ICUs) have thus 
increasingly used POCT as a routine element of patient 
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management [4–7], notably for blood gas analysis [8]. 
The primary objective of a blood gas analyzer (BGA) is 
to deliver accurate measures of blood gas levels (pH, pO2, 
pCO2); however, modern analyzers can currently meas-
ure additional parameters in the same blood sample, such 
as hemoglobin or electrolyte concentrations (sodium, 
potassium, chloride, and ionized calcium). POCT pro-
vides an adequate solution to obtain immediate results 
at the bedside [4], as abnormal blood electrolyte or 
hemoglobin concentrations need to be promptly cor-
rected for ICU patients. Nevertheless, previous studies 
assessing the concordance of POCT with central labora-
tory testing have reported divergent findings. Overdiag-
nosis of anemia or significant differences in electrolyte 
concentrations relative to central laboratory analyzers 
have been reported for POCT analyzers [9–11], whereas 
interchangeability was observed in others [6, 9, 10, 12]. 
Given the importance of laboratory test results on the 
final medical decision-making process, laboratory analy-
sis errors largely contribute to the overall risk of error. 
Accordingly, a majority of intensivists do not base impor-
tant clinical decisions on POCT results. Only 48 % of cli-
nicians make clinical decisions based on the potassium 
results obtained using a BGA without waiting for con-
firmation from the central laboratory [13, 14]. POCT in 
the ICU is currently used as complement to conventional 
laboratory services for the analysis of electrolyte and 
hemoglobin, but it is not a substitute, clearly limiting its 
impact and raising doubts about its relevance [8].
The increasing use of POCT is particularly challenging 
for POCT suppliers. POCT analyses are performed by 
non-laboratory staff, in diverse clinical contexts, in which 
the POCT users have varying levels of experience with 
the device. Suppliers of POCT analyzers are consequently 
concerned about ensuring consistency and quality of the 
analyses. The preanalytical phase, performed outside the 
direct supervision of laboratory professionals, could be 
an important reason for the underperformance of POCT 
[8]. However, most reported studies on POCT reliability 
have been mainly focused on the performance of the ana-
lyzer [9–11, 15] and not the preanalytical phase, including 
blood sampling and handling. Laboratory medicine is, not 
surprisingly, subject to error, but it is less well known that 
most laboratory errors occur during the manually inten-
sive activities of the preanalytical phase [16–18]. The aim 
of this study was to assess the reliability of POCT analyses 
in various testing environments and specific clinical con-
texts. We first studied the results for hemoglobin, potas-
sium, and sodium concentration measurements provided 
by BGAs delocalized in three specific clinical departments 
and compared these to the central laboratory results. The 
preanalytical management was modified due to substan-
tial analytical errors observed in different situations. We 
finally evaluated the impact of the preanalytical modifica-
tions on the POCT performance.
Methods
Setting
Three critical care units were involved in this study (see 
Table 1 for a detailed description):
  • Cardiac Surgery Operating Room (OR) with a BGA 
dedicated to one patient,
  • Neurosurgical ICU (10-bed ICU) with moderate 
BGA activity,
  • Polyvalent ICU (37-bed ICU) with elevated BGA 
activity.
Blood sampling and analysis
All patients included in the study had arterial cannula-
tion for ongoing blood pressure monitoring, which also 
allowed the simultaneous collection of blood samples 
from the arterial cannula for both blood gas POCT and 
central laboratory analysis. Purging of the arterial perfu-
sion line was performed using a standard (5 mL) closed 
system (Blood management system VAMP™ 60 in with 
Arm-mount Reservoir, Edwards Lifesciences™, Irvine, 
USA). A portion of the blood specimen was placed 
directly into a heparinized syringe for blood gas analysis 
and into collection tubes for central laboratory analysis 
(BD Vacutainer®, Le Pont de Claix, France). Paired sam-
ples were generated for each patient. The blood samples 
were thereafter transported at room temperature to the 
BGA and to the central laboratory for analysis.
All POCT for blood gas analysis was performed using 
the ABL 825® FLEX analyzer (Radiometer, Copenhagen, 
Denmark). Sodium and potassium measurements were 
based on the potentiometric method, performed by an 
ion-selective electrode. The total hemoglobin concentra-
tion was measured by spectrophotometry. The syringes 
used were: Syringe BD Preset™ (BD, Franklin Lakes, NJ, 
USA) in the 37-bed ICU and SafePICO® syringe (Radi-
ometer, Copenhagen, Denmark) in the Cardiac Sur-
gery OR and the 10-bed ICU. All BGA analyses were 
performed according to the manufacturers’ guidelines 
with special attention to the preanalytical conditions, 
including prevention of air contamination in the syringe, 
immediate analysis after collection, and proper mixing of 
blood syringes before introduction in the analyzer. Qual-
ity assurance according to the laboratory’s quality con-
trol procedure was performed on the BGAs and central 
laboratory analyzers. The maintenance of the BGAs was 
performed by the biochemical staff in accordance with 
the manufacturer’s guidelines. The results for automatic 
quality controls and calibrations were verified by the 
same biological staff.
Page 3 of 8Auvet et al. Ann. Intensive Care  (2016) 6:57 
In the central hospital laboratory, the hemoglobin con-
centration was analyzed using a Beckman Coulter Uni-
cel® DxH 800 analyzer (Beckman Coulter Inc., Miami, 
FL, USA) and electrolytes using an AU2700 chemistry 
analyzer (Beckman Coulter Inc., Miami, FL, USA). All 
analyses were performed by experienced laboratory 
technicians according to the manufacturer’s procedures. 
All instruments involved in the study were regularly 




We first calculated the biases between paired measure-
ments of potassium, sodium, and/or hemoglobin blood 
concentrations between the POCT and central laboratory 
for each of the three departments. From the point of view 
of POCT, the Cardiac Surgery OR may be considered to 
be a model of a “10-bed ICU” with almost perfect pre-
analytical conditions; limited preanalytical variation was 
therefore expected. We assumed that the results obtained 
under these conditions could serve as reference for opti-
mal preanalytical conditions (gold standard). We thus 
compared the biases obtained in the Cardiac Surgery OR 
to those obtained in 10-bed specialized ICU and 37-bed 
polyvalent ICU.
Step 2
A quality approach was implemented to improve the 
preanalytical process of the 37-bed ICU because large 
differences were observed between the biases calcu-
lated in the Cardiac Surgery OR and the 37-bed ICU (see 
“Results” section). Corrective actions were implemented 
after a multidisciplinary brainstorming involving the 
nurse managers, intensivists, and a clinical chemistry 
specialist. A new assessment of the POCT in the 37-bed 
ICU was then performed and compared to the gold 
standard.
Ethical considerations
This prospective, observational, non-interventional 
study was conducted at the University Hospital of Tours 
(France). The treatment of personal health data of this 
observational research has been approved by the Com-
mission Nationale de l’Informatique et des Libertés 
(CNIL). The study was also approved by an independent 
Research Ethics Committee (ERERC, Espace de Réflexion 
Ethique de la Région Centre). All patients included in this 
study were personally informed by a written document 
about the treatment of the data, as well as their right to 
object to the study and obtain access to the data, accord-
ing to articles L.1121-1 and R1121-2 of the French Public 
Health Code. The need for individual patient consent was 
Table 1 Detailed features of each care unit
Characteristics of point-of-care testing organization for each care unit
OR operative room, ICU intensive care unit, POCT point-of-care testing, BGA blood gas analyzer
Care unit
Cardiac Surgery OR Neurosurgical ICU Polyvalent ICU
Number of beds in the critical care 
unit
1 10 37
Nurse‑to‑patient ratio 1:1 1:2.5 1:3.7
Daily mean number of POCT 
analysis
20 7 55
BGA location Adjacent room in the cardiac sur‑
gery area, at a distance of 5 m
Central in the ICU, maximum of 
32 m from the farthest room
Central in the ICU, maximum of 80 m 
from the farthest room
Blood collection by arterial can‑
nulation
Yes Yes Yes
Care‑giver in charge of the blood 
sampling
Anesthesiologist and/or nurse 
anesthetist
Nurse Nurse
Care‑giver in charge of the POCT 
analysis
Anesthesiologist and/or nurse 
anesthetist
Nurse A care team member devoted to all 
POCT analyses (per quarter)
POCT user education Initial education, regular informa‑
tion
2 h a year, regular information 2 h quarterly, at traineeship start, and 
regular information
Phone assistance for POCT (24/7) Yes Yes Yes
Hemoglobin measurement on BGA Yes Yes Yes
Potassium and sodium concentra‑
tion measurement on BGA
Yes No Yes
Blood gas syringe used for POCT SafePICO® syringe SafePICO® syringe Syringe BD Preset™
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waived by the Research Ethics Committee as the study 
was considered to be a quality assurance project.
Statistical analysis
Quantitative data were reported as median values and 
interquartile range (IQR). Comparisons of quantita-
tive values were analyzed using the paired t test (for delay 
comparison, Gaussian distribution), and the Mann–Whit-
ney or Kruskal–Wallis test (and Dunn’s test for post hoc 
comparisons) depending on the number of groups to ana-
lyze. Determination of the agreement between labora-
tory (reference method) and POCT values was performed 
as described by Bland and Altman [19]. We plotted the 
average of each paired analysis against the difference for 
the same pair (central laboratory value  −  POCT value). 
Results are presented as bias [inferior limit of agreement 
(−1.96 SD); superior limit of agreement (+1.96 SD)]. It has 
been previously reported that for the comparison of meas-
urement methods, at least 53 paired-values for hemoglobin 
were necessary in operating theaters [20], whereas 127–202 
consecutive paired analyses were necessary for comparison 
in ICUs where higher variability is expected [21, 22]. Sta-
tistical analyses were performed using GraphPad Prism® 
v.5.0, and a p value <0.05 was considered to be significant.
Results
Step 1
In the first step of the study, we evaluated whether the 
measurement of hemoglobin and electrolyte (potassium, 
sodium) concentrations using a BGA could provide a 
valid alternative method to conventional laboratory test-
ing. Detailed results are listed in Table  2. The median 
time to obtain results was substantially reduced by POCT 
relative to the central laboratory in all critical care units:
2 [2–2] min instead of 82 [58–130] min (p < 0.0001) in 
the Cardiac Surgery OR,
5 [4–7] min instead of 80 [63–108] min (p < 0.0001) in 
the 10-bed ICU,
24 [13–38]  min instead of 112 [90–135]  min in the 
37-bed ICU (p < 0.0001).
The time required to obtain the results from the central 
laboratory did not significantly differ depending on the 
care units. In contrast, the turnaround times for POCT 
analyses were significantly different and markedly longer 
in both the 10-bed and 37-bed ICUs relative to the Car-
diac Surgery OR (p < 0.0001 for 10- or 37-bed ICU versus 
Cardiac Surgery OR and p < 0.0001 for 10- versus 37-bed 
ICU).
The bias and limits of agreements for hemoglobin con-
centrations in the Cardiac Surgery OR, 10- and 37-bed 
ICUs were: −3 [−6; 1], −5 [−28; 17], and −19 [−64; 
27]  g/L, respectively (Fig.  1a, b). The biases for hemo-
globin concentration were significantly different between 
the 37-bed ICU and the Cardiac Surgery OR (p < 0.0001), 
whereas we observed no statistical difference between 
the 10-bed ICU and Cardiac Surgery OR (p = 0.14).
Table 2 Comparison of hemoglobin, potassium, and sodium concentration measurements provided by the BGA in three 
critical care units with different preanalytical processes
Results are expressed as the median [IQR] or bias [inferior limits of agreement; superior limits of agreement]. n refers to the number of paired analyses
OR operative room, ICU intensive care unit, POCT point-of-care testing, lab. laboratory, conc. concentration, med. median, na non-available









Time for results (min)
 POCT 2 [2; 2] 5 [4; 7]* 24 [13; 38]* 15 [5; 29]*
 Central lab. 82 [58; 130] 80 [63; 108] 112 [90; 135] 119 [80; 144]
Hemoglobin conc. (g/L)
 POCT 129 [120–137] 108 [99–121] 115 [96–138] 93 [81–116]
 Central lab. 126 [116–134] 104 [95–116] 101 [82–112] 91 [79–110]
Bias [limits of agreement] −3 [−6; 1] −5 [−28; 17] −19 [−64; 27]* − 3 [−10; 5]
Potassium conc. (mmol/L)
 POCT 4.1 [3.9–4.3] na 4 [3.5–4.3] 4.2 [3.8–4.7]
 Central lab. 4.2 [4–4.5] na 4.1 [3.7–4.4] 4.3 [3.9–4.8]
Bias [limits of agreement] 0.1 [−0.1; 0.4] 0.1 [−0.1; 0.4] 0.1 [−0,3; 0,5]
Sodium conc. (mmol/L)
 POCT 139 [137–140] na 138 [135–142] 136 [134–139]
 Central lab. 139 [137–140] na 138 [135–142] 138 [135–140]
Bias [limits of agreement] 0 [−3; 3] 0 [−3; 3] 1 [−2; 4]
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The Bland–Altman plots for potassium and sodium con-
centrations in the Cardiac Surgery OR or 37-bed ICU are 
shown in Fig. 1a, b. The biases and limits of agreements for 
the electrolyte measurements were not significantly differ-
ent between the Cardiac Surgery OR and the 37-bed ICU 
(0 [−0.9; 0.8] and 0.1 [−0.1; 0.4]  mmol/L for potassium 
in the Cardiac Surgery OR and the 37-bed ICU, respec-
tively [p  =  0.17]; 0 [−3; 3] and 0 [−3; 3] for sodium in 
the Cardiac Surgery OR and the 37-bed ICU, respectively 
[p = 0.81]).
Step 2
A quality approach was implemented due to the poor 
agreement between the reliability of results provided by 
the BGA of the 37-bed ICU relative to the gold stand-
ard (BGA of Cardiac Surgery OR). The corrective actions 
were as follows:
  • All morning blood tests were routinely scheduled for 
analysis at 7:00 a.m. and a rush hour due to multiple 
analyses resulted in an increase of the POCT turna-
round time. We therefore reorganized the scheduled 
morning analysis to extend from 4:00 to 7:00 a.m. in 
three periods.
  • We implemented a checklist to validate the preana-
lytical conditions and set the maximum time allowed 
for the preanalytical phase.
  • We added a module on the ABL825® FLEX analyzer 
to provide automatic sample handling by succes-
sively identifying, mixing, aspirating, and measuring 
up to three blood gas samples (FLEXQ®, Radiom-
eter, Copenhagen, Denmark). Previous studies have 
clearly demonstrated the superiority of automatic 
mixing to produce a homogeneous sample [23, 24]. 
Cardiac Surgery OR
a b
37-bed ICU, Step 2
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Fig. 1 Bland–Altman plots for the comparisons between each method for estimating the hemoglobin, potassium, and sodium concentrations. 
Comparisons of the analyses were performed in a cardiac surgery operative room (OR), b polyvalent intensive care unit of 37 beds (37‑bed ICU). The 
preanalytical process of the 37‑bed ICU was improved according to the multidisciplinary quality approach, and a second run of comparisons was 
performed in this critical care unit (c). The solid red line in each Bland–Altman plot indicates the mean difference (bias) between the methods (value 
from the central laboratory − value from blood gas analyzer delocalized in the intensive care unit); the broken blue lines indicate the 95 % limits of 
agreement
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Moreover, this device reduces the turnaround time 
of the analyses due to an automatic syringe change.
  • We needed to switch the BD Preset™ 1-mL (BD, 
Franklin Lakes, NJ, USA) syringe for the SafePICO® 
syringe (Radiometer, Copenhagen, Denmark) to use 
the automatic FLEXQ® device.
We assessed the impact of the implementation on the 
process after modification of the preanalytical process 
of the 37-bed ICU based on the multidisciplinary qual-
ity approach. We observed a shorter POCT turnaround 
time relative to the first investigation: The duration of 24 
[13–38] min in Step 1 was reduced to 15 [5–29] min in 
Step 2 (p < 0.0001, Table 2). The time to obtain results for 
the central laboratory was unchanged (112 [90–135] min 
in Step 1 vs. 119 [80–144] min in Step 2, p = 0.85).
The bias for hemoglobin concentration was drastically 
reduced and was significantly different from that meas-
ured in Step 1: −2 [−10; 5]  g/L instead of −19 [−64; 
27] g/L (p < 0.0001) (Fig. 1c). We did not observe a sig-
nificant difference in the bias for the hemoglobin con-
centration between the 37-bed ICU (Step 2) and the 
Cardiac Surgery OR (p = 0.44). The biases for the potas-
sium and sodium concentrations were not modified by 
the modified preanalytical conditions of Step 2: 0.1 [−0.2; 
0.4]  mmol/L for potassium and 1 [−2; 4]  mmol/L for 
sodium.
Discussion
POCT has obvious theoretical advantages in ICUs: 
Numerous variables in a limited blood sample can be 
rapidly measured at the bedside without wasting time by 
transporting or centrifuging the sample. However, some 
concerns have been raised about the reliability of electro-
lyte and hemoglobin measurements performed by BGAs 
in clinical departments. Many hypotheses have been put 
forward to explain the discrepancies between POCT and 
core laboratory analyzers. The assumptions were mainly 
focused on analyzer performance. To our knowledge, we 
have clearly demonstrated, for the first time, that the pre-
analytical phase is the principal limiting factor in the ICU 
to obtain sufficient agreement between POCT and labo-
ratory analyzers. Finally, we highlight that preanalytical 
quality management, resulting from a multidisciplinary, 
point-by-point analysis, can lead to substantial improve-
ment in the final results provided by POCT analyzers.
 We considered the preanalytical conditions in the 
Cardiac Surgery OR to be almost perfectly controlled 
and assumed that the results obtained could serve as a 
reference for the optimal preanalytical phase of an ideal 
“10-bed ICU.” According to the US Clinical Labora-
tory Improvement Amendment (USCLIA) [25], potas-
sium, sodium, and hemoglobin biases found within ±0.5, 
±4  mmol/L, and ±7  %, respectively, of the target value 
are acceptable. Indeed, the results obtained in 2 min by 
POCT in the Cardiac Surgery OR were perfectly accept-
able: Potassium, sodium, and hemoglobin biases were 0.1 
[−0.1; 0.4], 0 [−3; 3] mmol/L, and −3 [−6; 1] g/L, respec-
tively (corresponding to 2.4 % of the target value). Thus, 
we confirmed that POCT of electrolytes and hemoglobin 
on a BGA (ABL 825® FLEX analyzer) generates rapid and 
accurate biological results under optimal preanalytical 
conditions. We were able to extrapolate this conclusion 
from a “10-bed ICU” to a 10-bed ICU, but failed with a 
larger ICU of 37 beds. We demonstrated that the pre-
analytical conditions were the principal cause of the final 
analytical errors, as the analyzers were identical. Fur-
thermore, all blood samples were collected in the same 
way on a dedicated arterial line that also excluded com-
mon errors of blood sampling, including hemolysis and 
sample contamination. It is thus highly probable that the 
large analytical discrepancies observed in the largest ICU 
were due to the difficulty of ensuring the consistency and 
quality of the preanalytical conditions. Indeed, it appears 
possible to control the source of errors in a 1- to 10-bed 
ICU, but it is clearly more challenging to minimize 
human error in a substantial ICU with a heavy workload.
The preanalytical phase of POCT could be particularly 
complex in the context of the ICU. It may be more dif-
ficult to standardize preanalytical processes than the 
analytical phase due to the various clinical situations. 
The preanalytical phase is probably different from one 
patient to another depending on the degree of emergency 
or severity. We developed a quality control strategy using 
a global, multidisciplinary approach, developed by rep-
resentatives of clinical, laboratory, and nursing staff, to 
determine and remove the cause of these random errors 
[26]. The quality control strategy included all steps of the 
analysis and was set up to reflect the exact conditions of 
clinical practice. Indeed, we systematically examined this 
process, from the bedside to the analyzer, and defined a 
small number of individual steps that must imperatively 
be carried out. We finally proposed a new care bundle to 
reduce variability of the preanalytical phase of POCT in 
the 37-bed ICU: definition of the upper time limit for the 
preanalytical phase according to the existing guidelines 
and local constraints [17]; modification of the organiza-
tion of the ICU to guarantee this limited delay; the use 
of existing technology to standardize the mixing of blood 
samples [23, 24]; implementation of a short checklist to 
confirm the successful completion of each step. With this 
care bundle approach, we emphasized the importance 
of pragmatically completing all important elements of 
care (rather than considering each element individually). 
Finally, we reduced the turnaround time between Steps 
1 and 2 by 38 % (24 [13–38]–15 [5–29] min). The benefit 
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of the care bundle was obvious in Step 2: The bias and 
unwarranted variation for hemoglobin was significantly 
decreased from −19 [−64; 27] to −2 [−10; 5] g/L.
This global approach may paradoxically be a limita-
tion in our study. We are unable to identify the precise 
role of each modification because all the modifications 
occurred at the same time. For example, we did not spe-
cifically assess the impact of reducing turnaround time 
on the final success of this care bundle. The choice of the 
syringe for POCT is also a well-known pitfall [27] that 
we did not investigate here. However, the study goal was 
not to puzzle out the random errors of the preanalyti-
cal phase through a series of deductions and research. It 
seems inappropriate, and even unethical, to determine 
step by step the improvement of POCT. On the contrary, 
the strength of our strategy was in supporting a prag-
matic analysis and then to tie the changes together into a 
bundle of interventions that was fully respected. Another 
limitation of the study design is the absence of sodium 
and potassium measurements in the 10-bed ICU. How-
ever, we observed that the measurement of these elec-
trolyte concentrations were not sensitive to the various 
preanalytical phases.
The suppliers of POCT are fully aware of their role in 
providing user assistance to guarantee the correct profes-
sional use of their tests, therefore providing reliable and 
safe results [28, 29]. As POCT is performed outside the 
walls of the laboratory by staff with a limited technical 
background, training and quality control can be critical 
[30]. Internal quality programs are already implemented 
by POCT suppliers: For example, the BGA automati-
cally performs quality controls, checks the analytical 
system, initiates necessary corrective actions, and docu-
ments all activities. However, the results provided by 
this study demonstrated that these systems cannot over-
come the issues generated during the preanalytical phase. 
Finally, our results underline that the underperformance 
of POCT can be significantly improved to provide more 
reliable results by a tight collaboration between users 
(ICU staff) and providers (laboratory staff).
Conclusion
Studies on the reliability of POCT of electrolytes and 
hemoglobin in the ICU by BGAs have provided conflict-
ing results. However, these previous studies were mainly 
focused on the analyzer rather than the preanalytical 
phase. The strength of this study was in integrating the 
global process of POCT, from the bedside to the final 
result. To our knowledge, we clearly demonstrate, for the 
first time, that an identical analyzer can provide results 
of varying quality depending on the local constraint of 
the ICUs. Further, we demonstrate that quality manage-
ment performed by the partners involved in the POCT 
can overcome these issues. It is now possible to bring 
laboratory tests closer to the patient, but it is impera-
tive to monitor their reliability in the exact condition of 
utilization.
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